Physician profile
Sarah E Hunt
NPI 1518342351
$1,480.57
in general payments reported to CMS, 2019-2025
17 companies · $290 in 2025
The $290 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $157 · 2023: $848 · 2024: $185 · 2025: $290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,323.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $207.37 | 2022-2023 | |
| Teva Pharmaceuticals USA, INC. | $195.32 | 2023-2024 | Austedo Xr, Austedo |
| Abbvie INC. | $171.87 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $144.61 | 2022-2023 | Ingrezza |
| Aop Health US, LLC | $143.19 | 2025 | Rapiblyk |
| Otsuka America Pharmaceutical, INC. | $124.99 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $91.65 | 2024-2025 | Imfinzi |
| Abiomed | $76.78 | 2023-2024 | Impella |
| Janssen Biotech, INC. | $66.40 | 2025 | Rybrevant |
| Merck Sharp & Dohme LLC | $58.23 | 2023-2024 | Keytruda |
| Pulmonx Corporation | $45.25 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Lundbeck LLC | $32.57 | 2023 | Rexulti |
| Baxter Healthcare | $29.07 | 2024 | Tisseel |
| Mirati Therapeutics, INC. | $25.11 | 2023 | Krazati |
| Ambu INC. | $25.00 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.41 | 2023 | |
| Ethicon US, LLC | $20.75 | 2023 | Echelon Endopath, Surgicel Nu-Knit, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Hunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.